Allergic rhinitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Men or women aged 18 to 60 years; 2. Those who have perennial allergic rhinitis; 3. Those who meet diagnostic criteria of allergic rhinitis; 4. Those who have not used any drugs or treatment methods for allergic rhinitis 2 weeks before the trial; 5. Those who accept ginger moxibustion treatment; 6. Those who are willing to cooperate with this trial treatment plan; 7. Those who are willing to sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to smoke and dust produced by moxibustion; 2. Those who are pregnant, breastfeeding during the study period; 3. Those who have serious disease related to the blood vessel, liver, kidney or haematopoietic system; 4. Those who have mental illness; 5. Those who are complicated with rhinosinusitis, otitis media, nasal polyps, nasal septum deviation and other ENT infections or organic lesions; 6. Those who have asthma and other paroxysmal respiratory diseases and are in the attack period; 7. Those who are participating in the other clinical trials of moxibustion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Nasal Symptom Score (TNSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Rhino Conjunctivitis Quality of Life Questionnaire (RQLQ); | — |
Countries
China
Contacts
Shanghai TCM-Integrated Hospital